Sharon E. Maynard

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Sharon E. Maynard, Jiang-Yong Min, Jaime R. Merchan et al. · Journal of Clinical Investigation · 2003 · 4K citations · Full text

Medicine, Maternal Health, Obstetrics +17

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Sharon E. Maynard, Jiangyong Min, Jaime R. Merchan et al. · Journal of Clinical Investigation · 2003 · 359 citations · Full text

Medicine, Maternal Health, Obstetrics +17

Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia

Richard J. Levine, Chun Sing Lam, Cong Qian et al. · Obstetrical & Gynecological Survey · 2007 · 216 citations

Public Health, Maternal Health, Obstetrics +14

Angiogenic factors for the prediction of preeclampsia in high-risk women

Tiffany A. Moore Simas, Sybil L. Crawford, Matthew J. Solitro et al. · American Journal of Obstetrics and Gynecology · 2007 · 184 citations

Medicine, Gynecology, Obstetrics +14

Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women

Richard J. Levine, Cong Qian, Sharon E. Maynard et al. · American Journal of Obstetrics and Gynecology · 2006 · 119 citations

Medicine, Gynecology, Obstetrics +14